Food and Drug Commissioner Scott Gottlieb on Friday left the door open to the possibility of asking more drug companies to take their prescription opioids off the market.
Gottlieb, who has worked for the FDA in a leadership role under other administrations, said that he thought a stronger approach was needed to tackle the opioid epidemic than had been carried out during the last decade when he said federal agencies were aware the problem but failed to get ahead of it.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
